CRISPR/Cas9 in CSC Research

CRISPR/Cas9 technology has revolutionized cancer research, providing a powerful tool to edit genes and study their functions in cancer stem cells (CSCs). This track focuses on how CRISPR/Cas9 is being used to investigate the genetic and epigenetic regulation of CSCs, identify novel therapeutic targets, and test potential drug candidates. Researchers use CRISPR to knock out specific genes involved in CSC self-renewal, survival, and therapy resistance, revealing new insights into CSC biology. This cutting-edge research aims to develop gene-editing strategies that selectively target CSCs, offering a highly specific approach to eradicating the cells responsible for cancer progression and relapse.

    Related Conference of CRISPR/Cas9 in CSC Research

    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands

    CRISPR/Cas9 in CSC Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in